The correct diagnosis should always be made by a specialized dermatologist. Depending on the case, the diagnosis may be based only on the clinical picture, and the history may require a hair scan, trichorizogram or biopsy of the scalp.

TREATMENT

The modern FUE method ensures the best possible aesthetic result both in the recipient area (where the new hair will enter) and in the donor area (the area where we will get the hair follicles).

Medicines

Medication has had limited success. Three drugs can mainly reduce rather than reverse androgenetic alopecia. Finasteride, dutasteride and minoxidil. In all three drugs the effect is reversible as soon as treatment is stopped. Injections of orticosteroids by injections into the scalp can be used to treat gyroid alopecia. This type of treatment is repeated on a monthly basis.

FUE TREATMENT

The operation is performed in septic surgery conditions and under local anesthesia and is divided into two main phases. The first concerns the extraction of hair follicles, the number of which is determined by many factors such as the ability of the donor area, the needs of the recipient area as well as the general needs of the patient. In the second phase, the hair follicles are implanted and at the end of it, the patient returns home with the instructions that he must follow until the first re-examination. For more information and complete information, call us at the doctor's office to answer any questions you may have.
Hair transplantation is the only method that can correct androgenetic alopecia. In hair transplantation, in essence, a redistribution of the remaining hairs of the scalp takes place, and this must be done in the best possible way. The main goal of the transplant is the natural result. But that alone does not make a transplant successful. The transplant should ensure that, 1) when the hair loss process continues the permanent hair that has been placed in the bald area will continue to give a natural image, 2 when the hair loss process continues, there will be hairs left in the donor area for a second or even a third transplant.